Reactive astrocytes foster brain metastases via STAT3 signaling
Author(s) -
Braden C. McFarland,
Etty Benveniste
Publication year - 2019
Publication title -
annals of translational medicine
Language(s) - English
Resource type - Journals
eISSN - 2305-5847
pISSN - 2305-5839
DOI - 10.21037/atm.2019.04.17
Subject(s) - stat3 , stat protein , brain metastasis , cancer research , tumor microenvironment , metastasis , signal transduction , immune system , medicine , transcription factor , neuroscience , biology , immunology , cancer , microbiology and biotechnology , gene , biochemistry
Brain metastasis remains a grim and complicating factor in many cancers, regardless of the primary tumor origin (1). Moreover, the unique brain microenvironment inadvertently aides in brain metastasis growth and progression (2). In a recently published paper by Priego et al . (3), it was uncovered that there is a subpopulation of reactive astrocytes (RA) that surround brain metastases and are driven by signal transducer and activator of transcription 3 (STAT3) activation. The metastatic tumor cells in the brain secrete various factors that trigger astrocytes to become reactive and display enhanced STAT3 activation. These STAT3+ RA produce cytokines and other factors that inhibit an appropriate anti-tumor immune response. Both innate and adaptive immune functions are compromised due to the activities of these STAT3+ RA. Targeting the STAT3 signaling pathway in the microenvironment helps reduce pro-tumorigenic signaling and decreases brain metastasis burden.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom